| Bing Li,Yuchen Bao,Bin Chen,Songwen Zhou. Therapy for non-small-cell lung cancer patients with brain metastases. Oncol Transl Med, 2014, 13: 483-488. |
| Therapy for non-small-cell lung cancer patients with brain metastases |
| Received:August 19, 2014 Revised:September 25, 2014 |
| View Full Text View/Add Comment Download reader |
| KeyWord:non?small?cell lung cancer (NSCLC); brain metastasis; whole?brain radiotherapy; surgery; stereotactic radiotherapy; chemotherapy; targeted therapy |
| Author Name | Affiliation | E-mail | | Bing Li | Department of Medical Oncology,Shanghai Pulmonary Hospital,Tongji University School of Medicine | libing044162@163.com | | Yuchen Bao | Department of Medical Oncology,Shanghai Pulmonary Hospital,Tongji University School of Medicine | | | Bin Chen | Department of Medical Oncology,Shanghai Pulmonary Hospital,Tongji University School of Medicine | | | Songwen Zhou | Department of Medical Oncology,Shanghai Pulmonary Hospital,Tongji University School of Medicine | zhou_songwen@126.com |
|
| Hits: 7908 |
| Download times: 9581 |
| Abstract: |
| Brain metastasis is a major cause of poor prognosis and high mortality for non-small cell lung cancer patients. The prognosis of non-small-cell lung cancer (NSCLC) patients with brain metastasis is generally poor and more effective treatment is required to improve their prognosis. Whole-brain radiotherapy, surgery, stereotactic radiosurgery, chemotherapy and targeted therapy are the main treatment for brain metastasis. This review focuses on the five therapeutic strategy and in particular, on targeted therapy. |
| Close |
|
|
|